![]() |
Cytori Gains Stem Cell Device Approval In Europe For Breast Cancer Reconstruction And
Cytori Therapeutics (NASDAQ: CYTX) received expanded European approval (CE Mark) for its Celution® System, a medical device that extracts and separates stem and regenerative cells from a patient's own fat tissue...
More... |
| All times are GMT -7. The time now is 01:17 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021